Research feed
Understand the finding first, then explore the evidence. Choose your reading level and sources independently.
Advanced research filters
Dates show original publication, separately from when we added the story. Clinical trials lists registry activity separately. Check collection coverage.
- Research review· Cardiac failure review
Meta-analysis estimates combined effect of quintuple heart failure therapy reduces cardiovascular death or HF hospitalisation
A cross-trial aggregate-data meta-analysis combined hazard ratios from six Phase III randomised trials to estimate the effect of quintuple disease-modifying therapy (including ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists, SGLT2 inhibitors, and vericiguat) versus conventional therapy in heart failure with reduced ejection fraction. The imputed combined effect showed HR 0.34 (95% CI 0.27–0.42) for cardiovascular death or first heart failure hospitalisation, HR 0.31 for first HF hospitalisation alone, HR 0.47 for cardiovascular death alone, and HR 0.51 for all-cause mortality.
Evidence assessment pending · META ANALYSIS
Read the study · Cardiac failure review ↗